DK0916679T3 - Phosphonsyresubstituerede benzazepinon-N-eddikesyrederivater samt fremgangsmåder til deres fremstilling og lægemidler indeholdende disse forbindelser - Google Patents

Phosphonsyresubstituerede benzazepinon-N-eddikesyrederivater samt fremgangsmåder til deres fremstilling og lægemidler indeholdende disse forbindelser

Info

Publication number
DK0916679T3
DK0916679T3 DK98120898T DK98120898T DK0916679T3 DK 0916679 T3 DK0916679 T3 DK 0916679T3 DK 98120898 T DK98120898 T DK 98120898T DK 98120898 T DK98120898 T DK 98120898T DK 0916679 T3 DK0916679 T3 DK 0916679T3
Authority
DK
Denmark
Prior art keywords
compounds
processes
preparation
well
drugs containing
Prior art date
Application number
DK98120898T
Other languages
English (en)
Inventor
Harald Dr Waldeck
Joerg Dr Meil
Dirk Dr Thormaehlen
Michael Dr Wurl
Original Assignee
Solvay Pharm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharm Gmbh filed Critical Solvay Pharm Gmbh
Application granted granted Critical
Publication of DK0916679T3 publication Critical patent/DK0916679T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK98120898T 1997-11-12 1998-11-04 Phosphonsyresubstituerede benzazepinon-N-eddikesyrederivater samt fremgangsmåder til deres fremstilling og lægemidler indeholdende disse forbindelser DK0916679T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19750002A DE19750002A1 (de) 1997-11-12 1997-11-12 Phosphonsäure-substituierte Benzazepinon-N-essigsäurederivate sowie Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel

Publications (1)

Publication Number Publication Date
DK0916679T3 true DK0916679T3 (da) 2002-12-16

Family

ID=7848410

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98120898T DK0916679T3 (da) 1997-11-12 1998-11-04 Phosphonsyresubstituerede benzazepinon-N-eddikesyrederivater samt fremgangsmåder til deres fremstilling og lægemidler indeholdende disse forbindelser

Country Status (28)

Country Link
US (1) US5952327A (da)
EP (1) EP0916679B1 (da)
JP (1) JP4162780B2 (da)
KR (1) KR19990045100A (da)
CN (1) CN1187361C (da)
AR (1) AR009911A1 (da)
AT (1) ATE228144T1 (da)
AU (1) AU746907B2 (da)
BR (1) BR9804582A (da)
CA (1) CA2253997C (da)
CZ (1) CZ296123B6 (da)
DE (2) DE19750002A1 (da)
DK (1) DK0916679T3 (da)
DZ (1) DZ2652A1 (da)
ES (1) ES2186961T3 (da)
HK (1) HK1019338A1 (da)
HU (1) HU221177B1 (da)
ID (1) ID21393A (da)
IL (1) IL126984A (da)
NO (1) NO317640B1 (da)
NZ (1) NZ332744A (da)
PL (1) PL191436B1 (da)
PT (1) PT916679E (da)
RU (1) RU2211219C2 (da)
SK (1) SK283233B6 (da)
TR (1) TR199802289A3 (da)
UA (1) UA60304C2 (da)
ZA (1) ZA9810316B (da)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0209855A (pt) * 2001-05-18 2004-06-15 Solvay Pharm Gmbh Uso de compostos com atividade inibidora de nep/mp combinada na preparação de medicamentos
AU2003206755B2 (en) * 2002-01-16 2008-07-17 Solvay Pharmaceuticals B.V. Solid salts benzazepine compounds and their use in the preparation of pharmaceuticals compounds
CL2004000544A1 (es) * 2003-03-18 2005-01-28 Pharmacia Corp Sa Organizada B Uso de una combinacion farmaceutica, de un antagonista del receptor de aldosterona y un inhibidor de endopeptidasa neutral, util para el tratamiento y prevencion de una condicion patologica relacionada con hipertension, disfuncion renal, insulinopati
US7427611B2 (en) * 2003-09-26 2008-09-23 Solvay Pharmaceuticals Gmbh Amidomethyl-substituted 1-(carboxyalkyl)-cyclopentyl-carbonylamino-benzazepine-N-acetic acid compounds, process and intermediate products for their preparation and pharmaceutical compositions containing them
US7262184B2 (en) * 2003-09-26 2007-08-28 Solvay Pharmaceuticals Gmbh Amidomethyl-substituted 1-(carboxyalkyl) cyclopentyl-carbonylamino-benzazepine-N-acetic acid compounds, process and intermediate products for their preparation and pharmaceutical compositions containing them
SA04250283B1 (ar) * 2003-09-26 2008-05-26 سولفاي فارماسيتيكالز جي أم بي أتش مشتقات من amidomethy1-substituted1-(carboxyalkyl)-cyclopentylcarbonylamino-benzazepine-N-acetic acid
US7452875B2 (en) 2003-09-26 2008-11-18 Solvay Pharmaceuticals Gmbh Amidomethyl-substituted 1-(carboxyalkyl) cyclopentyl-carbonylamino-benzazepine-N-acetic acid compounds, process and intermediate products for their preparation and pharmaceutical compositions containing them
WO2005067937A1 (en) * 2004-01-12 2005-07-28 Solvay Pharmaceuticals B.V. Neutral endopeptidase (nep) and human soluble endopeptidase (hsep) inhibitors for prophylaxis and treatment of neurodegenerative disorders
US7232813B2 (en) * 2004-01-12 2007-06-19 Solvay Pharmaceuticals B.V. Neutral endopeptidase (NEP) and human soluble endopeptidase (hSEP) inhibitors for prophylaxis and treatment of neuro-degenerative disorders
US20050267124A1 (en) * 2004-05-14 2005-12-01 Solvay Pharmaceuticals Gmbh Pharmaceutical compositions comprising NEP-inhibitors, inhibitors of the endogenous producing system and PDEV inhibiitors
US20050267072A1 (en) * 2004-05-14 2005-12-01 Solvay Pharmaceuticals Gmbh Pharmaceutical compositions containing dually acting inhibitors of neutral endopeptidase for the treatment of sexual dysfunction
US20050288272A1 (en) * 2004-06-23 2005-12-29 Solvay Pharmaceuticals Gmbh Pharmaceutical compositions comprising NEP-inhibitors, inhibitors of the endogenous endothelin producing system and AT1 receptor antagonists
CN101080232A (zh) 2004-12-15 2007-11-28 索尔瓦药物有限公司 包含NEP－抑制剂、内源性内皮素产生系统的抑制剂和HMG CoA还原酶抑制剂的药物组合物
US20060205625A1 (en) * 2005-02-18 2006-09-14 Solvay Pharmaceuticals Gmbh Pharmaceutical compositions comprising NEP-inhibitors, inhibitors of the endogenous endothelin producing system and diuretics
WO2007102171A2 (en) * 2006-03-07 2007-09-13 Panacea Biotec Ltd Novel salts of 1h-1-benzazepine-1-acetic acid, their preparation and pharmaceutical composition
US8198341B2 (en) 2008-12-18 2012-06-12 Icl-Ip America Inc. Method of making hydroxymethylphosphonate, polyurethane foam-forming compositions, polyurethane foam and articles made therefrom
CN104755487B (zh) 2012-10-17 2017-09-19 Icl-Ip美国有限公司 制备羟甲基膦酸酯的方法、由此制得的聚氨酯泡沫形成组合物、聚氨酯泡沫及制品
US9523195B2 (en) 2014-06-09 2016-12-20 Johns Manville Wall insulation boards with non-halogenated fire retardant and insulated wall systems
US9815256B2 (en) 2014-06-09 2017-11-14 Johns Manville Foam boards including non-halogenated fire retardants
US9528269B2 (en) 2014-06-09 2016-12-27 Johns Manville Roofing systems and roofing boards with non-halogenated fire retardant
US9815966B2 (en) 2014-07-18 2017-11-14 Johns Manville Spray foams containing non-halogenated fire retardants
CN107383084A (zh) * 2017-06-14 2017-11-24 浙江嘉华化工有限公司 一种0‑乙基磷酸钠的制备方法
PL424453A1 (pl) * 2018-01-31 2019-08-12 Forty-Four Pharmaceuticals Spółka Z Ograniczoną Odpowiedzialnością Sposoby zmniejszania szkodliwego działania niedoboru perfuzji narządów miąższowych przez inhibitory obojętnej endopeptydazy (NEP) i ludzkiej rozpuszczalnej endopeptydazy (hSEP)
PL424452A1 (pl) * 2018-01-31 2019-08-12 Forty-Four Pharmaceuticals Spółka Z Ograniczoną Odpowiedzialnością Inhibitory obojętnej endopeptydazy (NEP) i ludzkiej rozpuszczalnej endopeptydazy (hSEP) do profilaktyki i leczenia chorób oczu

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19510566A1 (de) * 1995-03-23 1996-09-26 Kali Chemie Pharma Gmbh Benzazepin-, Benzoxazepin- und Benzothiazepin-N-essigsäurederivate sowie Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
US5877313A (en) * 1995-05-17 1999-03-02 Bristol-Myers Squibb Benzo-fused azepinone and piperidinone compounds useful in the inhibition of ACE and NEP
US5635504A (en) * 1995-06-07 1997-06-03 Bristol-Myers Squibb Co. Diazepine containing dual action inhibitors

Also Published As

Publication number Publication date
HU221177B1 (en) 2002-08-28
CA2253997C (en) 2009-05-12
BR9804582A (pt) 2000-05-09
ZA9810316B (en) 1999-05-18
ATE228144T1 (de) 2002-12-15
NO985262D0 (no) 1998-11-11
HUP9802517A3 (en) 2000-06-28
RU2211219C2 (ru) 2003-08-27
ES2186961T3 (es) 2003-05-16
PT916679E (pt) 2003-03-31
UA60304C2 (uk) 2003-10-15
HUP9802517A2 (hu) 1999-09-28
TR199802289A2 (xx) 1999-06-21
HU9802517D0 (en) 1998-12-28
CN1187361C (zh) 2005-02-02
DZ2652A1 (fr) 2003-03-15
JP4162780B2 (ja) 2008-10-08
DE59806345D1 (de) 2003-01-02
IL126984A0 (en) 1999-09-22
EP0916679B1 (de) 2002-11-20
JPH11292886A (ja) 1999-10-26
US5952327A (en) 1999-09-14
NZ332744A (en) 2000-06-23
CA2253997A1 (en) 1999-05-12
NO317640B1 (no) 2004-11-29
TR199802289A3 (tr) 1999-06-21
SK151698A3 (en) 1999-05-07
ID21393A (id) 1999-06-03
CZ296123B6 (cs) 2006-01-11
DE19750002A1 (de) 1999-05-20
HK1019338A1 (en) 2000-02-03
CN1217334A (zh) 1999-05-26
KR19990045100A (ko) 1999-06-25
AU9234498A (en) 2000-06-08
SK283233B6 (sk) 2003-04-01
CZ356298A3 (cs) 1999-06-16
AU746907B2 (en) 2002-05-02
IL126984A (en) 2001-07-24
PL191436B1 (pl) 2006-05-31
NO985262L (no) 1999-05-14
PL329635A1 (en) 1999-05-24
AR009911A1 (es) 2000-05-03
EP0916679A1 (de) 1999-05-19

Similar Documents

Publication Publication Date Title
DK0916679T3 (da) Phosphonsyresubstituerede benzazepinon-N-eddikesyrederivater samt fremgangsmåder til deres fremstilling og lægemidler indeholdende disse forbindelser
DK0807111T3 (da) Substituerede heterocykliske forbindelser, fremgangsmåde til fremstillingen heraf samt farmaceutiske sammensætninger indeholdende disse
NO964700D0 (no) Nye aminosyrederivater, fremgangsmåte til deres fremstilling og farmasöytiske blandinger som inneholder disse forbindelser
DK1042355T3 (da) 11beta-halogen-7alfa-substituerede estratriener, fremgangsmåde til fremstilling af farmaceutiske præparater, der indeholder disse 11beta-halogen-7alfa-substituerede estratriener, samt deres anvendelse til fremstilling af lægemidler
DK1305281T3 (da) Substituerede sulfonylaminomethylbenzoesyre(derivater) samt fremgangsmåde til deres fremstilling
DE69811735D1 (de) Heterocyclische verbindungen zur hemmung der magensäureproduktion, verfahren zu ihrer herstellung und pharmazeutische zubereitungen davon
NO965377D0 (no) Indolinonforbindelser samt farmasöytiske preparater inneholdende forbindelsene
DK1086113T3 (da) Benzothiepin-1,1-dioxidderivater, fremgangsmåde til deres fremstilling, lægemidler med indhold af disse forbindelser og deres anvendelse
EE9700313A (et) Radiofarmatseutiliste ühendite valmistamise stabiilsed reagendid
NO961181D0 (no) Benzazepin-, benzoksazepin- og benzotiazepin-N-eddiksyre-derivater, fremgangsmåte for fremstilling samt legemiddel inneholdende disse forbindelser
NO20032735L (no) Difenylazetidinonderivater, fremgangsmåte for deres fremstilling, legemidler som inneholder disse forbindelsene samt deres anvendelse
DK0893064T3 (da) Lipidsammensætning til præparater til spædbørn samt fremstillingsfremgangsmåde for denne
DK0918059T3 (da) Susbstituerede imidazolidinderivater, deres fremstilling og anvendelse samt farmaceutiske præparater indeholdende disse derivater
NO933248D0 (no) Cykliske urinstoffderivater, legemidler inneholdende disse forbindelser, og fremgangsm}te for deres fremstilling
DK362787A (da) Benzensulfonamido-indanylforbindelser, laegemidler indeholdende disse forbindelser og fremgangsmaade til deres fremstilling
NO982176D0 (no) Korrosjonsinhiberte organiske syresammensetninger og fremgangsmÕter for anvendelse av disse
NO993001D0 (no) Farmas°ytiske aminofosfonsyrederivater
DK378988D0 (da) Dopamin-beta-hydroxylaseinhibitorer, fremgangsmaade til fremstilling heraf samt farmaceutiske midler indeholdende disse forbindelser
DK0838469T3 (da) 10,13,15-trioxatricyclo(9.2.1 9.6)-pentadecanon-derivater, fremgangsmåde til deres fremstilling og lægemidler indeholdende disse forbindelser
HUP9900344A3 (en) Process for the preparation of an optically active indoline-2-carboxylic acid or derivative thereof
DK457787A (da) Sulfonamidoethylforbindelser, laegemidler indeholdende disse forbindelser og fremgangsmaade til deres fremstilling
DK307085A (da) 4-phenyl-2-trifluormethyl-1,3-dioxan-5-ylheptensyrederivater, fremgangsmaade til fremstilling deraf samt farmaceutiske midler indeholdende disse
ID17326A (id) Turunan-turunan asam 4-arilbutirat tersubstitusi sebagai inhibitor-inhibitor matriks metalloprotease
NO960529L (no) Substituerte benzensulfonylureaer og -tioureaer, fremgangsmåte for fremstilling av disse, og deres anvendelse for fremstilling av farmasöytiske preparater samt farmasöytiske preparater inneholdende forbindelsene
EE03868B1 (et) Protsess O-(3-amino-2-hüdroksüpropüül) hüdroksüümhappehalogeniidide valmistamiseks